A recent study found that atorvastatin at its starting dosage reduces the risk of a first major cardiovascular event in patients with type 2 diabetes, said Helen Colhoun, MD, at the 64th scientific sessions of the American Diabetes Association (ADA) in Orlando.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Statin therapy should be considered for all patients with type 2 diabetes

Newsletter